ANESTHEZIA: what changed
ANESTHEZIA
Largest movements
- Cash +€73,191
up €73,191 (+61.5%), from €119,007 to €192,198
mainly Net result for the year (+€125,347) and Smaller working-capital items (+€65)
- Receivables within one year +€49,961
up €49,961 (+141%), from €35,364 to €85,325
of which Other amounts receivable: +€39,696
- Profit (loss) carried forward +€124,514
up €124,514 (+92.5%), from €134,570 to €259,084
- Gross operating margin -€14,331
down €14,331 (-8.2%), from €174,683 to €160,352
- Taxes -€3,402
down €3,402 (-8.7%), from €39,172 to €35,771
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €154,370 | €277,522 | +€123,152 | +79.8% |
| Current assets | 29/58 | €154,370 | €277,522 | +€123,152 | +79.8% |
| Amounts receivable within one year | 40/41 | €35,364 | €85,325 | +€49,961 | +141% |
| Trade receivables | 40 | €35,364 | €45,629 | +€10,265 | +29.0% |
| Other amounts receivable | 41 | - | €39,696 | +€39,696 | |
| Cash at bank and in hand | 54/58 | €119,007 | €192,198 | +€73,191 | +61.5% |
| Total equity and liabilities | 10/49 | €154,370 | €277,522 | +€123,152 | +79.8% |
| Equity | 10/15 | €135,570 | €260,084 | +€124,514 | +91.8% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €134,570 | €259,084 | +€124,514 | +92.5% |
| Amounts payable | 17/49 | €18,801 | €17,438 | -€1,362 | -7.2% |
| Amounts payable within one year | 42/48 | €18,801 | €17,438 | -€1,362 | -7.2% |
| Trade debts | 44 | €184 | €0 | -€184 | -100% |
| Suppliers | 440/4 | €184 | €0 | -€184 | -100% |
| Taxes, remuneration and social security | 45 | €16,022 | €16,272 | +€250 | +1.6% |
| Taxes | 450/3 | €16,022 | €16,272 | +€250 | +1.6% |
| Other amounts payable | 47/48 | €2,594 | €1,166 | -€1,428 | -55.0% |
| Gross operating margin | 9900 | €174,683 | €160,352 | -€14,331 | -8.2% |
| Operating profit (loss) | 9901 | €174,683 | €160,352 | -€14,331 | -8.2% |
| Financial income | 75/76B | - | €917 | +€917 | |
| Recurring financial income | 75 | - | €917 | +€917 | |
| Financial charges | 65/66B | €108 | €152 | +€44 | +40.3% |
| Recurring financial charges | 65 | €108 | €152 | +€44 | +40.3% |
| Profit (loss) for the period before taxes | 9903 | €174,575 | €161,118 | -€13,457 | -7.7% |
| Income taxes | 67/77 | €39,172 | €35,771 | -€3,402 | -8.7% |
| Profit (loss) for the period | 9904 | €135,403 | €125,347 | -€10,055 | -7.4% |
| Profit (loss) for the period to be appropriated | 9905 | €135,403 | €125,347 | -€10,055 | -7.4% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.